Biotechnology company developing genetic medicines for cardiovascular and other diseases.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Lexeo Therapeutics, Inc. in the last 30 days yet.
The 2 sources with the most insights about Lexeo Therapeutics, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
A speaker found the investment interesting but also described it as a struggling position, with the share price falling from roughly $10 to $3.
Mentioned as a biotech holding grouped with other negatively viewed positions, but no company-specific analysis was offered.
A speaker found the investment interesting but also described it as a struggling position, with the share price falling from roughly $10 to $3.
Mentioned as a biotech holding grouped with other negatively viewed positions, but no company-specific analysis was offered.
Other assets that creators frequently mention in the same content as Lexeo Therapeutics, Inc..
The most active sources covering Lexeo Therapeutics, Inc. (LXEO) on Kazuha are @realmartinshkreli, @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about Lexeo Therapeutics, Inc. (LXEO) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Lexeo Therapeutics, Inc. (LXEO) most frequently also discuss NKTR, SNDK, AMD, INTC, MU. See the "Discussed alongside" section above for full asset pages.